Putnam Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-46,460
| Closed | -$851K | – | 1154 |
|
|
2023
Q3 | $851K | Sell |
46,460
-402
| -0.9% | -$7.36K | ﹤0.01% | 857 |
|
|
2023
Q2 | $1.01M | Sell |
46,862
-1,459
| -3% | -$31.5K | ﹤0.01% | 844 |
|
|
2023
Q1 | $1.42M | Buy |
48,321
+25,289
| +110% | +$742K | ﹤0.01% | 807 |
|
|
2022
Q4 | $851K | Sell |
23,032
-13
| -0.1% | -$480 | ﹤0.01% | 857 |
|
|
2022
Q3 | $649K | Buy |
+23,045
| New | +$649K | ﹤0.01% | 903 |
|